攜程(09961.HK):設10億人幣旅遊創新基金
攜程集團-S(09961.HK)(TCOM.US)聯合創始人梁建章和CEO孫潔在攜程舉辦的行業峰會上宣布,將設立10億元人民幣旅遊創新基金,旨在支持旅遊領域的突破性和創新性發展,激勵在旅遊創新場景做出突出貢獻的項目和個人;與來自泰國、馬來西亞及印尼的多家國際酒店集團達成戰略合作,通過聯合營銷及服務升級提升區域酒店服務行業標準;以及聯合內地十個目的地及五家海外組團社構建「雙向服務樞紐」,響應國家促進入境旅遊戰略。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.